2012
DOI: 10.1371/journal.pone.0031934
|View full text |Cite
|
Sign up to set email alerts
|

High-Resolution Melting Analysis for the Rapid Detection of Fluoroquinolone and Streptomycin Resistance in Mycobacterium tuberculosis

Abstract: BackgroundMolecular methods for the detection of drug-resistant tuberculosis are potentially more rapid than conventional culture-based drug susceptibility testing, facilitating the commencement of appropriate treatment for patients with drug resistant tuberculosis. We aimed to develop and evaluate high-resolution melting (HRM) assays for the detection of mutations within gyrA, rpsL, and rrs, for the determination of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis (MTB).Methodology/Pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
21
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 51 publications
1
21
0
Order By: Relevance
“…In view of this mandate, we have developed and evaluated for the first time, to our knowledge, an HRM-based assay for direct testing of mutations responsible for RIF and INH resistance in sputum samples from a primarily M. tuberculosis SSM-negative group (84/99 samples). HRM has been proposed earlier as an alternative to conventional DST and was employed successfully as a molecular DST method for RIF, INH, and other drugs, including fluoroquinolones, streptomycin, and pyrazinamide, primarily on clinical isolates (8)(9)(10)(11)(12)(13)(14)(15)(16)19).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In view of this mandate, we have developed and evaluated for the first time, to our knowledge, an HRM-based assay for direct testing of mutations responsible for RIF and INH resistance in sputum samples from a primarily M. tuberculosis SSM-negative group (84/99 samples). HRM has been proposed earlier as an alternative to conventional DST and was employed successfully as a molecular DST method for RIF, INH, and other drugs, including fluoroquinolones, streptomycin, and pyrazinamide, primarily on clinical isolates (8)(9)(10)(11)(12)(13)(14)(15)(16)19).…”
Section: Discussionmentioning
confidence: 99%
“…This method is a potentially good substitute for conventional DST in clinical practice and has been evaluated previously for the detection of RIF resistance in M. tuberculosis culture isolates from sputum, with an overall sensitivity and specificity of 94% and 99%, respectively (8). HRM has also been used successfully as a molecular DST for other drugs, including isoniazid (INH), fluoroquinolones, streptomycin, and pyrazinamide, in M. tuberculosis clinical isolates from sputum, with a sensitivity range of 74 to 100% and specificity range of 83 to 100% (9)(10)(11)(12)(13)(14)(15)(16). A microfluidic TaqMan array card that utilizes sequence-specific probes and HRM has also been reported for the detection of mutations involved in MDR and extensively drug-resistant TB (XDR-TB) in clinical isolates, with 96% accuracy (17).…”
mentioning
confidence: 99%
“…rpsL encodes for the ribosomal protein S12 subunit, and mutations within rpsL are associated with streptomycin resistance (44). rpoB encodes for DNA-dependent RNA polymerase, and mutations within rpoB can result in rifampicin resistance (44,45).…”
Section: Discussionmentioning
confidence: 99%
“…rpoB encodes for DNA-dependent RNA polymerase, and mutations within rpoB can result in rifampicin resistance (44,45). dnaK encodes heat shock protein that is the most abundant protein within Mtb and plays a crucial role in preventing partially misfolded proteins from aggregating by binding to hydrophobic residues, which then allows these proteins to refold (46).…”
Section: Discussionmentioning
confidence: 99%
“…HRMA is a rapid, simple, cost-effective, and closed-tube method, and it has been applied to a variety of diseases, such as inherited, infectious, and oncological diseases (14). This PCR-based method was successfully used for rapid identification and susceptibility testing of Mycobacterium tuberculosis in previous studies (2,4,15,16). On the other hand, previous studies have demonstrated that RIF resistance is a good surrogate marker for MDR-TB, especially when molecular methods are used for rapid detection of RIF-resistant M. tuberculosis isolates, as 90% of RIF-resistant M. tuberculosis isolates, or an even greater proportion, are also resistant to INH (17)(18)(19)(20).…”
mentioning
confidence: 99%